A controlled study of the prophylactic portacaval shunt. A final report.
D000328:Adult; D000428:Alcohol Drinking; D000437:Alcoholism / Q000150:complications; D001201:Ascites / Q000453:epidemiology; D001663:Bilirubin / Q000097:blood; D001927:Brain Diseases / Q000453:epidemiology; D002986:Clinical Trials as Topic; D004185:Disability Evaluation; D004932:Esophageal and Gastric Varices / Q000401:mortality / Q000517:prevention & control*; D006471:Gastrointestinal Hemorrhage / Q000401:mortality / Q000517:prevention & control*; D006760:Hospitalization; D006801:Humans; D006975:Hypertension, Portal / Q000601:surgery*; D008103:Liver Cirrhosis / Q000209:etiology / Q000601:surgery*; D008111:Liver Function Tests; D008875:Middle Aged; D010437:Peptic Ulcer / Q000453:epidemiology; D011167:Portacaval Shunt, Surgical; D011446:Prospective Studies; D011517:Prothrombin Time; D012709:Serum Albumin / Q000032:analysis; D012959:Socioeconomic Factors; D013997:Time Factors
D012709:Serum Albumin; D001663:Bilirubin